Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

China flag China · Delayed Price · Currency is CNY
31.23
-0.12 (-0.38%)
Mar 20, 2026, 3:00 PM CST
Market Cap4.79B -22.5%
Revenue (ttm)3.18B -20.1%
Net Income326.30M -23.8%
EPS2.16 -22.7%
Shares Out153.40M
PE Ratio14.48
Forward PEn/a
Dividend0.90 (2.87%)
Ex-Dividend DateApr 30, 2025
Volume1,085,825
Average Volume1,191,072
Open31.31
Previous Close31.35
Day's Range31.09 - 31.60
52-Week Range31.03 - 48.14
Beta0.41
RSI33.23
Earnings DateMar 21, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It provides medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China. [Read more]

Sector Healthcare
Founded 1993
Employees 2,345
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600976
Full Company Profile

Financial Performance

In 2024, SHA:600976's revenue was 3.50 billion, a decrease of -16.81% compared to the previous year's 4.21 billion. Earnings were 362.18 million, a decrease of -30.54%.

Financial Statements